Cancer Stem Cells in Tumor Pathogenesis after Cryoablation
Keywords:malignancy, cancer stem cells, cryoablation
The review highlights some areas of malignant tumor treatment, particularly the cryosurgery of solid tumors. There is discussed the possibility of using the method of cryoablation as a tool for targeting and inactivation of cancer stem cells, being the main structural unit, initiating, maintaining growth and tumor metastasis. The publications regarding the phenotypic and functional characteristics of tumor-inducing cells, including both more potent CSCs and advanced in the differentiation of their descendants, the nature of cold factor impact on them were analyzed. The main ways to optimize the use of cryoablation technique in clinical practice are under consideration.
Probl Cryobiol Cryomed 2015; 25(3):205-218
Baust J.G., Gage A.A. Progress toward optimization of cryo-surgery. Techn Cancer Res Treat 2004; 3 (2): 95â€“101. CrossRef
Bergsagel D.E., Valeriote F.A. Growth characteristics of a mouse plasma cell tumor. Cancer Res 1968; 28 (11): 2187â€“2196. PubMed
Bondarovich N.A., Ostankova L.V., Sirous M.A. et al. Using fetal liver cells to correct the immune system of C3H line mice. Svit Meditsyny i Biologii 2007; (1): 40â€“46.
Breda A., Lam J.S., Riggs S. et al. In vivo efficacy of laparoscopic assisted percutaneous renal cryotherapy: evidence based guidelines for the practicing urologist. J Urol 2008; 79 (1): 333â€“337. CrossRef PubMed
Bruce W.R., Van Der Gaag H. A quantitative assay for the number of murine lymphoma cells capable of proliferation in vivo. Nature 1963; 199: 79â€“80. CrossRef
Clarke M.F., Dick J.E., Dirks P.B. et al. Cancer stem cells-perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res 2006; 66 (19): 9339â€“9344. CrossRef PubMed
Clarke D.M., Hollister W.R., Baust J.G., Van Buskirk R.G. Cryosurgical modeling sequence of freezing and cytotoxic agent application affects cell death. Mol Urol 1999; 3 (1): 25â€“31. PubMed
Cohnheim J. Ueber entzundung und eiterung. Path Anat Physiol Klin Med 1867; 40: 1â€“79. CrossRef
Croker A.K., Goodale D., Chu J. et al. High aldehyde dehydro-genase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability. J Cell Mol Med 2009; 13 (8B): 2236â€“2252. CrossRef PubMed
Diabina O.A., Ostankov M.V., Bondarovich N.A., Goltsev A.N. Freeze-thawing-cycle-dependent cryoability of Ehrlich carcinoma stem-like cells. Proceedings of 50th anniversary celebration annual scientific conference&AGM "Freezing biological time". London, UK; 2014, p. 73.
Gaitanis G, Bassukas I. Intralesional bevacizumab as in-add adjuvant to immunocryosurgery for locally advanced basal cell carcinoma. J Eur Acad Dermatol Venerol 2014; 28 (8): 1117â€“1121. CrossRef PubMed
Ghebeh H., Sleiman G.M., Manogaran P.S. et al. Profiling of normal and malignant breast tissue show CD44high/CD24low phenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers. BMC Cancer 2013; 13: 289â€“303. CrossRef PubMed
Goltsev A.N., Babenko N.N., Gaevskaya Yu. A. et al. The ability of orthovanadates-based nanoparticles to identify in vitro and in vivo inhibition of cancer stem cells // Proceedings of IV International conference 'Nanoscale systems: structure, properties, technology'; Kyiv: NANSIS, 2013, 15 p.
Goltsev A.N., Babenko N.N., Gaevskaya Yu. A. et al. Inactivation of Ehrlich adenocarcinoma growth after treatment with orthovanadatesâ€“based nanoparticles. Proceedings of the IV International Scientific Conference 'Nanostructured Materials'; Minsk; 2014, p. 394â€“395.
Goltsev A.M., Bondarovich M.O., Kuznyakov A.V. et al. Determination of immunity T-cell link state and content of cancer stem cells as a criterion to estimate efficiency of preventive breast cancer therapy with cryopreserved fetal liver cells. Problems of Cryobiology and Cryomedicine 2014; 24 (3): 238â€“248. CrossRef
Goltsev A.N., Bondarovich N.A., Kuznyakov A.V. et al. State of immune status and cell pool with cancer stem cells features in C3H mice with determined breast cancer development after administering cryopreserved fetal liver cells. Proceedings of 50th Anniversary Celebration, Annual Scientific Conference & AGM 'Freezing biological time'; London, UK; 2014, P. 68.
Goltsev A.N., Chelombitko O.V., Bondarovich. N.A. et al. Cryo-preservation effect on pluripotency gene expression in Ehrlich carcinoma cells Proceedings of 50th Anniversary Celebration, Annual Scientific Conference & AGM 'Freezing biological time'; London, UK; 2014, p. 84.
Goltsev A.N., Dyabina O.A, Yampolskaya E.E. et al. Features of response of Ehrlich adenocarcinoma cancer stem cells on cryotherapy. Proceedings of the International Conference 'Theoretical and practical aspects of modern cryobiology'; Syktyvkar; 2014, p. 335â€“340.
Goltsev A.M., Safranchuk O.V., Bondarovich M.O. et al. Change of cancer stem cells cryolability in the process of Ehrlich adenocarcinoma cultivating in vivo. Fiziologichny Zhurnal 2011; (4): 68â€“76.
Goltsev A.M., Safranchuk, O.V. Chelombitko O.V. et al. Assess-ment of functional activity of Ehrlich adenocarcinoma tumor stem cells after interaction with orthovanadats-based nano-particles. Proceedings of the 4th Interdisciplinary Conference 'Biologically active materials: fundamentals and applied problems of production and application'; Novyi Svet, Crimea; 2013, p. 385â€“386.
Gonder M.J., Soanes W.A., Smith V. Experimental prostate cryosurgery. Invest Urol 1964; (1): 610â€“619. PubMed
Green H.N., Crockett S.D., Martyshkin D.V. et al. A histological evaluation and in vivo assessment of intratumoral near infrared photothermal nanotherapy-induced tumor regression. Int J Nanomedicine 2014; 9 (1): 5093â€“5102. CrossRef PubMed
Guo Z. Pay attention to the problems in cryoablation therapy for prostate cancer Zhonghua Yi Xue Za Zhi (National Medical Journal of China) 2010; 90 (42): 2959â€“2961. PubMed
Hinshaw J.L., Littrup P.J., Durick N. et al. Optimizing the protocol for pulmonary cryoablation: a comparison of a dual- and triple-freeze protocol. Cardiovasc Intervent Radiol 2010; 33(6): 1180â€“1185. CrossRef PubMed
Jaggupilli A., Elkord E. Significance of CD44 and CD24 as can-cer stem cell markers: an enduring ambiguity. Clin Dev Immunol 2012; 2012: 1â€“11.
Jeha S., Coustan-Smith E., Pei D. et al. Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome-positive acute lympho-blastic leukemia. Cancer 2014; 120 (10): 1514â€“1519. CrossRef PubMed
Joosten J.J., Muijen G.N., Wobbes T., Ruers T.J. In vivo destruction of tumor tissue by cryoablation can induce inhibition of secondary tumor growth: an experimental study. Cryo-biology 2001; 42 (1): 49â€“58. CrossRef PubMed
Kashihara H., Shimada M., Kurita N. et al. CD133 expression is correlated with poor prognosis in colorectal cancer. Hepatogas-troenterology 2014; 61 (134): 1563â€“1567. PubMed
Kim F.J., Cerqueira M.A., Almeida J.C. et al. Initial Brazilian experience in the treatment of localized prostate cancer using a new generation cryotechnology: feasibility study. Int Braz J Urol 2012; 38 (5): 620â€“626. CrossRef PubMed
Kinoshita S., Harada J., Kanetsuna Y. et al Initial experience of percutaneous cryoablation to treat small cancer of the breast. Low temp Med 2014; 40 (1): 4â€“10.
Li Y.H., Elshafei A., Agarwal G. et al. Salvage focal prostate cryoablation for locally recurrent prostate cancer after radiotherapy: Initial results from the cryo on-line data registry. Prostate 2015; 75 (1): 1â€“7. CrossRef PubMed
Lim S.H., Jang J., Park J.O. CD133â€“positive tumor cell content is a predictor of early recurrence in colorectal cancer. J Gastro-intest Oncol 2014; 5 (6): 47â€“56.
Lim S.H., Spring K.J., de Souza P., MacKenzie S., Bokey L. Circulating tumour cells and circulating nucleic acids as a mea-sure of tumour dissemination in non-metastatic colorectal cancer surgery. Eur J Surg Oncol 2015; 41 (3): 309â€“314. CrossRef PubMed
Liu J., Deng Z.S. Nano-cryosurgery: advances and challenges. J Nanosci Nanotechnol 2009; 9 (8): 4521â€“4542. CrossRef
Long J.P., Bahn D., Lee F. et al. Five-year retrospective multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate. Urology 2001; 57 (3): 518â€“523. CrossRef
Manenti G., Perretta T., Gaspari E. et al. Percutaneous local ablation of unifocal subclinical breast cancer: clinical expe-rience and preliminary results of cryotherapy. Eur Radiol 2011; 21 (11): 2344â€“2353. CrossRef PubMed
Park C.H., Bergsagel D.E., McCulloch E.A. Mouse myeloma tumor stem cells: a primary cell culture assay. J Natl Cancer Inst 1971; 46 (2): 411â€“422. PubMed
Rao W., Bellotti A., Littrup P.J. et al. Nanoparticle-encapsulated doxorubicin enhances cryoablation of cancer stem-like cells. Technology 2014; 2: 28â€“35. CrossRef
Robilotto A.T., Baust J.M., Van Buskirk R.G. et al. Temperature-dependent activation of differential apoptotic pathways during cryoablation in a human prostate cancer model. Prostate Cancer Prostatic Dis 2013; 16 (1): 41â€“49. CrossRef PubMed
Saroufim A., Messai Y., Hasmim M. et al. Tumoral CD105 is a novel independent prognostic marker for prognosis in clearâ€“cell renal cell carcinoma. Br J Cancer 2014; 110 (7): 1778â€“1784. CrossRef PubMed
Shah T.T., Ahmed H., Kanthabalan A. et al. Focal cryotherapy of localized prostate cancer: a systematic review of the litera-ture. Expert Rev Anticancer Ther 2014; 14 (11): 1337â€“1347. CrossRef PubMed
Shibata T., Yamashita T., Suzuki K. et al. Enhancement of experimental pulmonary metastasis and inhibition of subcu-taneously transplanted tumor growth following cryosurgery. Anticancer Res 1998; 18 (6A): 4443â€“4448. PubMed
Sugiyama Y., Saji S., Miya K. Therapeutic effect of multimodal therapy, such as cryosurgery, locoregional immunotherapy and systemic chemotherapy against far advanced breast cancer. Gan To Kagaku Ryoho 2001; 28 (11): 1616â€“1619. PubMed
Sun Z.Q., Yang Y., Liu J. In vivo experiments and numerical investigations on nanocryosurgical freezing of target tissues with large blood vessels. J Biomed Nanotechnol 2012; 8 (1): 10â€“18. CrossRef PubMed
Tarkowski R., Rzaca M. Cryosurgery in the treatment of women with breast cancer â€“ a review. Gland Surgery 2014; 3 (2): 88â€“93. PubMed
Wassmann B., Pfeifer H., Goekbuget N. et al. Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL). Blood 2006; 108 (5): 1469â€“477. CrossRef PubMed
Weigmann A., Corbeil D., Hellwig A., Huttner W.B. Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells. Proc Natl Acad Sci USA 1997; 94 (23): 12425â€“12430. CrossRef PubMed
Yamashita T., Hayakawa K., Hosokawa M. et al. Enhanced tu-mor metastasis in rats following cryosurgery of primary tumor. Gann 1982; 73: 222â€“228. PubMed
Yin A.H., Miraglia S., Zanjani E.D. et al. AC133, is a novel mar-ker for human hematopoietic stem and progenitor cells. Blood 1997; 90 (12): 5002â€“5012. PubMed
Yu Q., Yi J., Zhao G., Zhang Y. Effect of vascular network and nanoparticles on heat transfer and intracellular ice for-mation in tumor tissues during cryosurgery. CryoLetters 2014; 35 (2): 95â€“100.
Zakharychev V.D., Samedov V.Kh. Complex treatment of oral mucosa cancer. Klin Khir 2013; (9): 13â€“16. PubMed
Zeng Y., Wodzenski D., Gao D. et al. Stressâ€“response protein RBM3 attenuates the stemâ€“like properties of prostate cancer cells by interfering with CD44 variant splicing. Cancer Res. 2013; 73 (13): 4123â€“4133. CrossRef PubMed
Zhang D.G., Jiang A.G., Lu H.Y. et al. Isolation, cultivation and identification of human lung adenocarcinoma stem cells. Oncol Lett 2015; 9 (1): 47â€“54. PubMed
Zhang L., Li H., Ge C. et al. Inhibitory effects of transcription factor Ikaros on the expression of liver cancer stem cell marker CD133 in hepatocellular carcinoma. Oncotarget 2014; 5 (21): 10621â€“10635.
How to Cite
Copyright (c) 2020 Anatoliy N. Goltsev, Olga A. Diabina, Maksim V. Ostankov, Nikolay A. Bondarovich, Ekaterina Ye. Yampolskaya
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).